This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by An, H.-X. Articles by Niederacher, D. Search for Related Content PubMed PubMed Citation Articles by An, H.-X. Articles by Niederacher, D.

(American Journal of Pathology. 1999;154:113-118.)
© 1999 American Society for Investigative Pathology

Regular Articles

Gene Amplification and Overexpression of CDK4 in Sporadic Breast Carcinomas Is Associated with High Tumor Cell Proliferation

Han-Xiang An* , Matthias W. Beckmann* , Guido Reifenberger , Hans G. Bender* and Dieter Niederacher*

From the Department of Obstetrics and Gynecology,* and Center for Biological and Medical Research (BMFZ), Heinrich-Heine-University, Düsseldorf, Germany and the Department of Neuropathology, University of Bonn, Germany

Amplification of the cyclin-dependent kinase 4 (CDK4) gene, located at 12q13-q14, has been found as an alternative genetic alteration to CDKN2A inactivation in various human tumors including malignant gliomas and sarcomas. In the present study, we have evaluated the frequency of the CDK4 gene amplification in sporadic breast cancer by applying a nonradioactive quantitative differential polymerase chain reaction based on fluorescent DNA technology. Fluorescent-labeled polymerase chain reaction products were analyzed with an automated DNA sequencer. Amplification of CDK4 gene was detected in 15 (15.8%) of 95 breast cancers. All tumors with CDK4 gene amplification showed high CDK4 protein expression determined by immunohistochemistry. Furthermore, the mean Ki-67 labeling index in tumors with CDK4 gene amplification was significantly higher than in those without CDK4 gene amplification. No significant associations were observed between CDK4 gene amplification and any specific histopathological parameter. The findings of this study provide the first evidence of CDK4 gene amplification in breast cancer and suggest that CDK4 gene amplification appears to be of importance in the pathogenesis of a subset of sporadic breast cancer.

This article has been cited by other articles:

				L. Hernandez, S. Bea, M. Pinyol, G. Ott, T. Katzenberger, A. Rosenwald, F. Bosch, A. Lopez-Guillermo, J. Delabie, D. Colomer, et al. CDK4 and MDM2 Gene Alterations Mainly Occur in Highly Proliferative and Aggressive Mantle Cell Lymphomas with Wild-type INK4a/ARF Locus Cancer Res., March 15, 2005; 65(6): 2199 - 2206. [Abstract] [Full Text] [PDF]

				P. L. Miliani de Marval, E. Macias, R. Rounbehler, P. Sicinski, H. Kiyokawa, D. G. Johnson, C. J. Conti, and M. L. Rodriguez-Puebla Lack of Cyclin-Dependent Kinase 4 Inhibits c-myc Tumorigenic Activities in Epithelial Tissues Mol. Cell. Biol., September 1, 2004; 24(17): 7538 - 7547. [Abstract] [Full Text] [PDF]

				M. L. Rodriguez-Puebla, P. L. Miliani de Marval, M. LaCava, D. S. Moons, H. Kiyokawa, and C. J. Conti cdk4 Deficiency Inhibits Skin Tumor Development but Does Not Affect Normal Keratinocyte Proliferation Am. J. Pathol., August 1, 2002; 161(2): 405 - 411. [Abstract] [Full Text] [PDF]

				U. Lehmann, S. Glockner, W. Kleeberger, H. F. R. von Wasielewski, and H. Kreipe Detection of Gene Amplification in Archival Breast Cancer Specimens by Laser-Assisted Microdissection and Quantitative Real-Time Polymerase Chain Reaction Am. J. Pathol., June 1, 2000; 156(6): 1855 - 1864. [Abstract] [Full Text] [PDF]

				Y. Takano, Y. Kato, P. J. van Diest, M. Masuda, H. Mitomi, and I. Okayasu Cyclin D2 Overexpression and Lack of p27 Correlate Positively and Cyclin E Inversely with a Poor Prognosis in Gastric Cancer Cases Am. J. Pathol., February 1, 2000; 156(2): 585 - 594. [Abstract] [Full Text] [PDF]